📰 Annem Hause News
Annem Hause News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Annem Hause. Real-time updates on events, politics, business and more.
June 15, 2023
No new safety concerns reported among children aged 6 months to 5 years receiving third dose of mRNA COVID-19 vaccine.
June 13, 2023
No new safety concerns reported among children aged 6 months to 5 years receiving third dose of mRNA COVID-19 vaccine.
August 2, 2022
Investigators probed ystemic reactions among those receiving both flu and COVID-19 vaccines compared with COVID-19 mRNA booster alone.
July 20, 2022
A fourth dose of mRNA COVID-19 vaccine seems safe for immunocompromised individuals aged 12 years or older.
July 19, 2022
A fourth dose of mRNA COVID-19 vaccine seems safe for immunocompromised individuals aged 12 years and older.
July 14, 2022
Among children aged 5 to 11 years, most reported adverse events to BNT162b2 COVID-19 vaccination are mild-to-moderate.
July 12, 2022
Based on data from three U.S. safety monitoring systems, adverse events were mild-to-moderate, and myocarditis occurred rarely.
March 9, 2022
For adolescents aged 12 to 17 years, reactions to homologous Pfizer-BioNTech booster vaccination occur with similar frequency as after receipt of the second vaccine dose.
March 3, 2022
This report describes safety monitoring after a Pfizer-BioNTech booster vaccination among children and adolescents aged 12-17 years.
March 2, 2022
This report describes safety monitoring after a Pfizer-BioNTech booster vaccination among children and adolescents aged 12-17 years.